Category: Insights

Drug repurposing patent documents vs peer review: patent information comes more than 600 days earlier on average

This article was originally published by Hermann Mucke & Peter Mucke in Future Drug Discovery under a Attribution-NonCommercial-NoDerivatives 4.0 Unported License. https://doi.org/10.4155/fdd-2020-0001. Drug developers require access to scientific info…


244 Drug Patents With Claims Containing “consisting essentially of” may be Unenforceable

In a recent court ruling, the U.S. Court of Appeals for the Federal Circuit (CAFC) denied a petition to rehear arguments regarding the invalidity of patent claims containing the phrase…
The post 244 Drug Patents With Claims Containing “consisting essen…


Do NOT follow this link or you will be banned from the site!